Imprivata
Executives
16Board of Directors
5Imprivata Board of Directors
5 Board of directors
Imprivata has 5 board of directors, including David Barrett.
Name | Firm | Work History | Other Seats |
|---|---|---|---|
David Barrett | Dave brings years of entrepreneurial and operating success to his investment partnering, including the building and scaling of extreme–growth teams at Lotus Development/IBM, Pure Atria/Rational/IBM, and Calico (IPO). His Board success has included LogMeIn (NASDAQ: LOGM), Imprivata (NASDAQ: IMPR) MarkMonitor (Thomson Reuters), Phytel (IBM), Automattic/Wordpress and Centra Software (NASDAQ: CTRA). With an investment focus on SaaS, cloud infrastructure and data science, current partner companies in addition to Egnyte include: Confluence, InsideSales, Lob, Notarize, and Recurly. He’s been recognized as an Always–On VC 100 and VC East “Power Player” as result of investment returns success over the last five years. He also serves on the Dana–Farber Cancer Institute Board of Trustees. | Imprivata | |
David Orfao | Decades of senior operating experience, including a decade as a leading venture capitalist, and pioneering PC software companies such as Lotus, Ashton Tate, Frame Technology and Apple’s Claris division. Founding managing partner of General Catalyst Partners. | Imprivata | |
Gus Malezis | Gus Malezis is the President and Chief Executive Officer of Imprivata. Gus is widely recognized as a visionary leader in the information technology security industry where he brings more than 30 years of experience driving innovation and growth while building market leading organizations. Prior to joining Imprivata, Gus was most recently the President of Tripwire, a leading global provider of endpoint detection and response, security and compliance solutions. In his career, Gus has built a strong track record of delivering growth and innovation for leading technology and security companies such as Tripwire, McAfee, and 3Com. He combines extensive knowledge of global markets including North America, Europe, and Asia with strong technical knowledge and a passion for enabling customer success in the rapidly changing IT marketplace. Gus has extensive background and expertise in information security and compliance, networking, network systems management, CRM, and application design and development. Gus studied Computer Science and Philosophy at the University of Toronto. | Imprivata | |
Paul Maeder | Paul Maeder has been our Chief Financial Officer since inception. From 1987 to the Present, Mr. Maeder has been General Partner and the Chair of Highland Capital Partners, a venture capital company. From 1984 to 1987, Mr. Maeder served as General Partner of Charles River Ventures, a venture capital company. Prior to joining Charles River Ventures, Mr. Maeder was an Engineer and Project Manager of Synemed, Inc., a biomedical engineering products company. Mr. Maeder also serves on the board of 2U (2010-Present) and Exagrid, Inc. (2017-Present). Mr. Maeder has an MBA from Harvard Business School, an MS from Stanford University, and a BSE from Princeton University. | Imprivata | |
Scott Crabill | Scott joined Thoma Bravo in 2002 from the Palo Alto, CA office of Summit Partners, a leading private equity firm, where he invested in and worked with companies in various sectors, including software, technology and business services. Previously, he was with the private equity firm of J.H. Whitney & Co., Stamford, CT, where he was active in middle-market buyouts and growth equity financings across a wide range of industries. He also worked at Hewlett-Packard as a product manager and at Alex. Brown & Sons in corporate finance and in mergers and acquisitions. Scott earned a BS degree in Industrial Engineering from Stanford University and an MBA degree from the Stanford Graduate School of Business. | Imprivata |
Name | David Barrett | David Orfao | Gus Malezis | Paul Maeder | Scott Crabill |
|---|---|---|---|---|---|
Firm | |||||
Work History | Dave brings years of entrepreneurial and operating success to his investment partnering, including the building and scaling of extreme–growth teams at Lotus Development/IBM, Pure Atria/Rational/IBM, and Calico (IPO). His Board success has included LogMeIn (NASDAQ: LOGM), Imprivata (NASDAQ: IMPR) MarkMonitor (Thomson Reuters), Phytel (IBM), Automattic/Wordpress and Centra Software (NASDAQ: CTRA). With an investment focus on SaaS, cloud infrastructure and data science, current partner companies in addition to Egnyte include: Confluence, InsideSales, Lob, Notarize, and Recurly. He’s been recognized as an Always–On VC 100 and VC East “Power Player” as result of investment returns success over the last five years. He also serves on the Dana–Farber Cancer Institute Board of Trustees. | Decades of senior operating experience, including a decade as a leading venture capitalist, and pioneering PC software companies such as Lotus, Ashton Tate, Frame Technology and Apple’s Claris division. Founding managing partner of General Catalyst Partners. | Gus Malezis is the President and Chief Executive Officer of Imprivata. Gus is widely recognized as a visionary leader in the information technology security industry where he brings more than 30 years of experience driving innovation and growth while building market leading organizations. Prior to joining Imprivata, Gus was most recently the President of Tripwire, a leading global provider of endpoint detection and response, security and compliance solutions. In his career, Gus has built a strong track record of delivering growth and innovation for leading technology and security companies such as Tripwire, McAfee, and 3Com. He combines extensive knowledge of global markets including North America, Europe, and Asia with strong technical knowledge and a passion for enabling customer success in the rapidly changing IT marketplace. Gus has extensive background and expertise in information security and compliance, networking, network systems management, CRM, and application design and development. Gus studied Computer Science and Philosophy at the University of Toronto. | Paul Maeder has been our Chief Financial Officer since inception. From 1987 to the Present, Mr. Maeder has been General Partner and the Chair of Highland Capital Partners, a venture capital company. From 1984 to 1987, Mr. Maeder served as General Partner of Charles River Ventures, a venture capital company. Prior to joining Charles River Ventures, Mr. Maeder was an Engineer and Project Manager of Synemed, Inc., a biomedical engineering products company. Mr. Maeder also serves on the board of 2U (2010-Present) and Exagrid, Inc. (2017-Present). Mr. Maeder has an MBA from Harvard Business School, an MS from Stanford University, and a BSE from Princeton University. | Scott joined Thoma Bravo in 2002 from the Palo Alto, CA office of Summit Partners, a leading private equity firm, where he invested in and worked with companies in various sectors, including software, technology and business services. Previously, he was with the private equity firm of J.H. Whitney & Co., Stamford, CT, where he was active in middle-market buyouts and growth equity financings across a wide range of industries. He also worked at Hewlett-Packard as a product manager and at Alex. Brown & Sons in corporate finance and in mergers and acquisitions. Scott earned a BS degree in Industrial Engineering from Stanford University and an MBA degree from the Stanford Graduate School of Business. |
Other Seats | Imprivata | Imprivata | Imprivata | Imprivata | Imprivata |
Imprivata Management Team
16 Team Members
Imprivata has 16 executives. Imprivata's founder is David Ting. Imprivata's current Chief Executive Officer, President is Gus Malezis.
Name | Work History | Title | Status |
|---|---|---|---|
David Ting | Kodak, Atex, Delphax Technologies, and Bell | Founder | Current |
Gus Malezis | Chief Executive Officer, President | Current | |
James E. Carr | Chief Financial Officer | Current | |
Wes Wright | Sutter Health, Seattle Children's Research Institute, Scripps Health, and U.S. Air Force | Chief Technology Officer | Current |
Todd Morley | Medtronic, Alteryx, Teradata, Clear Peak, Pitney Bowes, and Oracle | Senior Vice President | Current |
Name | David Ting | Gus Malezis | James E. Carr | Wes Wright | Todd Morley |
|---|---|---|---|---|---|
Work History | Kodak, Atex, Delphax Technologies, and Bell | Sutter Health, Seattle Children's Research Institute, Scripps Health, and U.S. Air Force | Medtronic, Alteryx, Teradata, Clear Peak, Pitney Bowes, and Oracle | ||
Title | Founder | Chief Executive Officer, President | Chief Financial Officer | Chief Technology Officer | Senior Vice President |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.